Skip to Main Content

Paper Details

In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer.
Clin Cancer Res
12
2021
Author NameAffiliation
Ultan McDermottWellcome Sanger Institute
Ultan McDermott
Mark LawlerQueen's University Belfast
  • 1 - 3

Datasets

Release 1.2